RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, bl...
RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
With the aging population, the prevalence and incidence of cerebrovascular disease will continue to rise, as well as the number of individuals with vascular cognitive impairment/dementia (VCID). No specific FDA-approved treatments for VCID exist. Although clinical evidence supports that angiotensin receptor blockers (ARBs) prevent cognitive decline...
Alternative Titles
Full title
RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_656ea8b917cd41a0b5dede0fe73be8f9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_656ea8b917cd41a0b5dede0fe73be8f9
Other Identifiers
ISSN
1742-2094
E-ISSN
1742-2094
DOI
10.1186/s12974-018-1262-x
